# Seyed Hamid Khoee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/seyed-hamid-khoee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 207 |
| Field | Pharmaceutical Practices and Patient Outcomes |
| h-index | 7 |
| i10-index | 6 |
| Last Known Institution | Tehran University of Medical Sciences |
| OpenAlex ID | https://openalex.org/A5082572362 |
| Works | 16 |

## Researcher papers

- [Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial](https://scholariq.org/papers/long-term-effects-of-addition-of-mineralocorticoid-receptor-antagonist-to/)
- [A review of medication errors in iran: sources, underreporting reasons and preventive measures.](https://scholariq.org/papers/a-review-of-medication-errors-in-iran-sources-underreporting-reasons-and/)
- [A review of medication errors in Iran: Sources, underreporting reasons and preventive measures](https://scholariq.org/papers/a-review-of-medication-errors-in-iran-sources-underreporting-reasons-and-2/)
- [Assessment of cyclosporine serum concentrations on the incidence of acute graft versus host disease post hematopoietic stem cell transplantation.](https://scholariq.org/papers/assessment-of-cyclosporine-serum-concentrations-on-the-incidence-of-acute-graft/)
- [Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT).](https://scholariq.org/papers/vancomycin-pharmacokinetic-parameters-in-patients-undergoing-hematopoietic-stem/)
- [Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)](https://scholariq.org/papers/vancomycin-pharmacokinetic-parameters-in-patients-undergoing-hematopoietic-stem-2/)
- [Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients](https://scholariq.org/papers/comparative-efficacy-and-safety-of-atorvastatin-simvastatin-and-lovastatin-in-2/)
- [Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients](https://scholariq.org/papers/comparative-efficacy-and-safety-of-atorvastatin-simvastatin-and-lovastatin-in/)
- [Comparative efficacy of daily versus alternate-day dosing of atorvastatin in Type 2 diabetic patients](https://scholariq.org/papers/comparative-efficacy-of-daily-versus-alternate-day-dosing-of-atorvastatin-in/)
- [The prevalence of antifungal agents administration in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study.](https://scholariq.org/papers/the-prevalence-of-antifungal-agents-administration-in-patients-undergoing/)

## Researcher topics

- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Patient Safety and Medication Errors](https://scholariq.org/topics/patient-safety-and-medication-errors/)

## Researcher university

- [Tehran University of Medical Sciences](https://scholariq.org/institutions/tehran-university-of-medical-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.